Whipplewood Advisors, LLC United Therapeutics Corp Transaction History

Whipplewood Advisors, LLC

  • $152 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
BUY
$276.47 - $328.4 $1,935 - $2,298
7 Added 46.67%
22 $6.32 Million
Q1 2025

Apr 09, 2025
SELL
$304.42 - $380.78 $2,130 - $2,665
-7 Reduced 31.82%
15 $6.78 Million
Q4 2024

Feb 04, 2025
BUY
$348.66 - $410.0 $7,670 - $9,020
22 New
22 $7.76 Million

Others Institutions Holding UTHR

# of Institutions
804
Shares Held
41.4M
Call Options Held
1.56M
Put Options Held
2.86M
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Whipplewood Advisors, LLC Portfolio

Follow Whipplewood Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whipplewood Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whipplewood Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email